ClinConnect ClinConnect Logo
Search / Trial NCT06963983

Virtual Reality Rehabilitation for Shoulder Pathologies

Launched by LA TOUR HOSPITAL · Apr 30, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new rehabilitation approach using virtual reality (VR) to help patients with shoulder problems, such as shoulder instability, frozen shoulder, and rotator cuff tears. The goal is to make rehabilitation more engaging and motivating by using games that patients can play while doing their exercises. This method aims to improve recovery by keeping patients interested and allowing them to track their progress easily, making therapy more enjoyable and effective.

To participate in this study, you need to be an adult who can understand and sign the consent form. Eligible candidates include those who have had surgery for shoulder instability, have had a partial or complete rotator cuff repair, or suffer from frozen shoulder. Participants will attend four VR therapy sessions, where they will perform exercises designed to help their condition in a fun and interactive way. It's important to note that certain individuals, such as those with severe mental health issues or specific medical conditions, may not be able to participate. Overall, this trial hopes to explore whether VR can significantly improve shoulder rehabilitation outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients able to understand the content of the patient information / consent form and give consent to take part in the research project
  • Glenohumeral instability surgical treated with traumatic initial instability in a \< 20 years old athlete, recurrent instability with one or more of the following criteria: a failure of conservative treatment, locked dislocation, failed prior surgery, high risk for further recurrence (i.e. collision or competitive athletes), Critical glenoid bone-loss (\>15-20%), bipolar bone-loss resulting in "off-track" lesion
  • Partial or complete rotator cuff repair with an indication to postoperative rehabilitation depending on surgeon recommendation
  • Idiopathic, primary, or secondary frozen shoulder
  • Exclusion Criteria:
  • Patients with a language barrier hindering questionnaires completion
  • Patients unlikely to attend clinical follow-up (e.g. when living abroad)
  • Legal incompetence
  • Enrolment of the investigators, his/her family members, employees and other dependent persons
  • Non-motivated patients
  • Active infection
  • Exclusion criteria related to glenohumeral instability: uncontrolled epilepsy, spontaneous unidirectional instability in a hyperlax patient, multidirectional instability, elher-Danlos syndrome
  • Exclusion criteria related to rotator cuff tears: Additional procedure(s) (muscle transfer, patch,...)
  • Exclusion criteria related to VR use: Patients with a predisposition to motion sickness, Patients suffering from epilepsy or having any serious mental illness (schyzophrenia, neurological problems, etc.), Patients with visual impairment , Patients will intellectual disability that prevent them to understand how to use the VR rehabilitation system, Patients with bilateral upper limb injuries, as one side is needed as healthy reference

About La Tour Hospital

La Tour Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. With a commitment to excellence, the hospital offers state-of-the-art facilities and a multidisciplinary team of experienced professionals who collaborate to ensure the highest standards of safety and efficacy in research. La Tour Hospital actively engages in a diverse range of clinical studies across various therapeutic areas, aiming to contribute valuable insights that enhance treatment options and improve patient outcomes. Its focus on ethical practices and regulatory compliance reinforces its reputation as a trusted sponsor in the clinical research community.

Locations

Meyrin, Geneva, Switzerland

Patients applied

0 patients applied

Trial Officials

Alexandre Lädermann, MD

Principal Investigator

La Tour hospital, Meyrin (1217) Geneva, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported